Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 31;14(4):519-530.
doi: 10.4103/tjo.TJO-D-23-00108. eCollection 2024 Oct-Dec.

Vitrectomy for diabetic retinopathy: A review of indications, techniques, outcomes, and complications

Affiliations
Review

Vitrectomy for diabetic retinopathy: A review of indications, techniques, outcomes, and complications

Nimesh C Patel et al. Taiwan J Ophthalmol. .

Abstract

Diabetic retinopathy is one of the most severe forms of retinopathy and a leading cause of blindness all over the world. Of a greater concern is proliferative diabetic retinopathy which leads to vitreous haemorrhage and tractional retinal detachment in such cases. A majority of these cases require a surgical intervention to improve vision and prevent further vision loss. Surgical manouevers in these cases require a complex combination of vitrectomy, membrane dissection, judious usage of endodiathermy, endolaser, vital dyes, bimanual dissection and usage of intraoperative and post-operative tamponades. Each case presents a unique challenge and necessitates an appropriate combination of the steps mentioned above. In the current review we present the current understanding of the need for surgery in diabetic retinopathy, various surgical approaches and a summary of current literature on the same. Multiple surgical video clips demonstrating these steps are also included in this review.

Keywords: Diabetic vitrectomy; posterior hyaloid; proliferative diabetic retinopathy; subhyaloid hemorrhage; vitreous hemorrhage.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interests of this paper.

Figures

Figure 1
Figure 1
Pre and post fundus photograph of subhyaloid hemorrhage
Figure 2
Figure 2
Pre and post photograph of vitreomacular traction and adhesion
Figure 3
Figure 3
Pre and post fundus photo of progressive fibrovascular proliferation

Similar articles

Cited by

References

    1. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64. - PMC - PubMed
    1. Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A meta-analysis from 1990 to 2010. Diabetes Care. 2016;39:1643–9. - PubMed
    1. Sabanayagam C, Banu R, Chee ML, Lee R, Wang YX, Tan G, et al. Incidence and progression of diabetic retinopathy: A systematic review. Lancet Diabetes Endocrinol. 2019;7:140–9. - PubMed
    1. Wirkkala J, Bloigu R, Hautala NM. Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy. BMJ Open Ophthalmol. 2019;4:e000390. - PMC - PubMed
    1. Zhou AY, Zhou CJ, Yao J, Quan YL, Ren BC, Wang JM. Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy. Int J Ophthalmol. 2016;9:1772–8. - PMC - PubMed

LinkOut - more resources